Delivery Order SPE2DR25D2013-SPE2DR26F5QVR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,482.11 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 11, 2025, with completion expected by December 12, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $49,813.65 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 17, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $19,070.71 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $34,205.63 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $23,676.54 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 26, 2025, with a completion date of December 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $13,245.31. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitively awarded, non-set-aside contract. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement that extends through December 2026. The contract represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $11,313.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price delivery order, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $22,670.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 12, 2025, with a completion date of June 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QVRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,092.10 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 26, 2025, with a completion date of December 29, 2025. This firm fixed-price contract, classified as non-competitive with no set-aside designation, leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement (SPE2DX) extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order represents a routine pharmaceutical supply transaction under the broader DLA Troop Support Medical prime vendor vehicle, which enables comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Jardiance, a diabetes management medication, aligns with AmerisourceBergen's extensive portfolio of specialty pharmaceuticals and medical supplies distributed through multiple therapeutic domains under federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 12/25/25 |